Evidence map›Paper›PMID 32285289›Full record

ArticleGeroScience2020

Long-term treatment with spermidine increases health span of middle-aged Sprague-Dawley male rats.

Madalina Filfan, Andrei Olaru, Ion Udristoiu, Claudiu Margaritescu, Eugen Petcu, Dirk M Hermann, Aurel Popa-Wagner

Open access · greenAbstract read
In one paragraph

Article in GeroScience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Madalina FilfanDoctoral School, University of Medicine and Pharmacy, Craiova, Romania.
Andrei OlaruDepartment of Ophtalmology, University of Medicine and Pharmacy, Craiova, Romania.
Ion UdristoiuDepartment of Psychiatry, University of Medicine and Pharmacy, Craiova, Romania.
Claudiu MargaritescuDepartment of Pathology, University of Medicine and Pharmacy, Craiova, Romania.
Eugen PetcuGold Coast Campus and Queensland Eye Institute, Griffith University Menzies Health Institute of Queensland, QLD, Brisbane, 4000, Australia.
Dirk M HermannChair of Vascular Neurology, Dementia and Ageing Research, Department of Neurology, University Hospital Essen, Germany, University of Duisburg-Essen, Duisburg, Germany.
Aurel Popa-WagnerDepartment of Pathology, University of Medicine and Pharmacy, Craiova, Romania. aurel.popa@uk-essen.de.
University of Medicine and Pharmacy of Craiova · ROGriffith University · AUUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Let alone calorie restriction, life span extension in higher organisms has proven to be difficult to achieve using simple drugs. Previous studies have shown that the polyamine spermidine increased the maximum life span in C. elegans and the median life span in mice. However, younger subjects (< 40 years of age) are infrequently prescribed nor self-medicating with antiaging drugs. Therefore, in the present study, we aimed at assessing the effect of long-term treatment with spermidine given in the drinking water on behavioral performance and longevity of male, middle-aged Sprague-Dawley rats. We report that spermidine given in the drinking water did not extend neither the median nor the maximum life span of the middle-aged male Sprague-Dawley rats. However, spermidine treatment had a beneficial effect on the body weight and the kidney tubules, liver, and heart morphology. Behaviorally, spermidine led to a reduction in anxiety and an increase in curiosity, as assessed by exploratory behavior. Moreover, long-term treatment with spermidine enhanced autophagy in the brain and led to a diminished expression of the inflammatory markers, Tgfb, CD11b, Fcgr1, Stat1, CR3, and GFAP mRNAs in several cortical region and hippocampus of the treated rats suggesting that one beneficial effect of the long-term treatment with spermidine is an attenuated proinflammatory state in the aged brain. Our results suggest that long-term treatment with spermidine increases health span of middle-aged rats by attenuating neuroinflammation and improving anxiety and exploratory behavior.

Indexed as

Caenorhabditis elegansSpermidineAnimalsAutophagyLongevityMaleMiceRatsRats, Sprague-DawleySpermidineAutophagyBehaviorLongevityMiddle-aged ratsNeuroinflammationSpermidine

Identifiers

PMID32285289
PMCPMC7287009
OpenAlexW3015594687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.